Hatice Yücel
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
-
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
Papers in
-
- DNA Repair Mechanisms 3
- CRISPR and Genetic Engineering 2
- Epigenetics and DNA Methylation 1
- Cancer therapeutics and mechanisms 1
- Gene expression and cancer classification 1
- Oncology 4
- PARP inhibition in cancer therapy 3
- CAR-T cell therapy research 1
- Co-authors
- Raphaël Ceccaldi (3 shared papers)Alan D. D’Andrea (2 shared papers)Jos Jonkers (3 shared papers)Marieke van de Ven (2 shared papers)Sven Rottenberg (2 shared papers)Ewa Gogola (1 shared paper)Alexandra A. Duarte (1 shared paper)Panagiotis A. Konstantinopoulos (1 shared paper)
- Journals
- Genes & Development (1 paper)Nature Cell Biology (1 paper)Molecular Cell (1 paper)Nature Cancer (1 paper)Oncotarget (1 paper)
- Partner nations
- NetherlandsSwitzerlandFrance
In The Last Decade
Hatice Yücel
5 papers receiving 595 citations
Hatice Yücel's Hit Papers
Peers
Comparison fields: 5 of 45
- Oncology 366
- Molecular Biology 506
- Cancer Research 62
- Reproductive Medicine 34
- Genetics 89
Countries citing papers authored by Hatice Yücel
This map shows the geographic impact of Hatice Yücel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatice Yücel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatice Yücel more than expected).
Fields of papers citing papers by Hatice Yücel
This network shows the impact of papers produced by Hatice Yücel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatice Yücel. The network helps show where Hatice Yücel may publish in the future.
Co-authors
The 25 scholars most cited alongside Hatice Yücel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 256 | |
| 2 | A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors Hit paper breakdown → | 2021 | 226 |
| 3 | 2016 | 100 | |
| 4 | 2017 | 12 | |
| 5 | 2025 | 3 | |
| 6 | 2025 | 0 |
About Hatice Yücel
Hatice Yücel is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 6 papers that have together received 597 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (3 papers), CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (1 paper), Epigenetics and DNA Methylation (1 paper), Effects of Radiation Exposure (1 paper), Cancer therapeutics and mechanisms (1 paper) and Gene expression and cancer classification (1 paper). The work is most often cited by research in Oncology (366 citations), Molecular Biology (506 citations), Cancer Research (62 citations), Reproductive Medicine (34 citations) and Genetics (89 citations). Hatice Yücel has collaborated with scholars based in Netherlands, Switzerland and France. Frequent co-authors include Raphaël Ceccaldi, Alan D. D’Andrea, Jos Jonkers, Marieke van de Ven, Sven Rottenberg, Ewa Gogola, Alexandra A. Duarte, Panagiotis A. Konstantinopoulos, Beatrice Rondinelli and Jia Zhou. Their work appears in journals such as Genes & Development, Nature Cell Biology, Molecular Cell, Nature Cancer and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.